Sargent Investment Group, LLC Cytosorbents Corp Transaction History
Sargent Investment Group, LLC
- $546 Million
- Q3 2024
A detailed history of Sargent Investment Group, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Sargent Investment Group, LLC holds 1,626,247 shares of CTSO stock, worth $1.5 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
1,626,247
Previous 1,433,500
13.45%
Holding current value
$1.5 Million
Previous $1 Million
143.17%
% of portfolio
0.45%
Previous 0.21%
Shares
25 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
16.7MCall Options Held
15.4KPut Options Held
0-
Avenir Corp Washington, DC2.98MShares$2.74 Million0.45% of portfolio
-
Skylands Capital, LLC2.76MShares$2.53 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.09MShares$1.93 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.79 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.78MShares$1.64 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $40.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...